Autres langues BioElectronics Corporation

Actions

BIEL

US09062H1086

Equipement et technologie médicale avancés

Marché Fermé - OTC Markets 17:36:59 03/06/2026			Varia. 5j.	Varia. 1 janv.
0,000400 ^USD	-.--%		+33,33%	-

21/07	Bioelectronics Corporation agrandit son siège social dans le Maryland en louant des bureaux adjacents	CI
17/06	BioElectronics Corporation et Electrome Corporation accélèrent le déploiement commercial d'ActiPatch via un accord de distribution et de licence	CI

Autres langues

21/07	BioElectronics Corporation Doubles Facility Space to Support Electrome's Commercial ActiPatch Launch and Anticipated Sales Growth
21/07	Bioelectronics Corporation Expands Maryland Headquarters by Leasing Adjacent Office Suite
30/06	BioElectronics Issues Chairman's Update Highlighting Sales Growth, and Strategic Progress
17/06	BioElectronics Advances ActiPatch Commercial Rollout With Electrome
17/06	BioElectronics Corporation and Electrome Corporation Advance ActiPatch Commercial Rollout with Distribution and Licensing Agreement
22/04	BioElectronics Corporation Launches ActiPatch In Taiwan
24/03	Electrome Corp and BioElectronics Corp Enter Strategic Partnership for Bioelectric Pain Management Platform
03/12/24	Sree Koneru, PhD Joins the Board of Directors of BioElectronics Corporation
03/12/24	BioElectronics Corporation Appoints Sree Koneru to Its Board of Directors
16/10/24	BioElectronics Corporation's Chairman Updates Investors
21/05/24	BioElectronics Corporation Announces Utility Patent Application Filing
25/03/24	BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study
25/03/24	BioElectronics Corporation Announces the Publication of a Canine Arthritis Study
23/02/24	BioElectronics Corporation Announces the Publication of Pilot Study Results
23/02/24	Bioelectronics Corporation Announces the Publication of Pilot Study Results
15/02/24	BioElectronics Chairman Updates Investors
22/12/23	End of Year Message From the Chairman of the Board of BioElectronics
26/08/22	BioElectronics : BIEL QTR2 Disclosure Statement
15/08/22	BioElectronics : BIEL QTR2 Disclosure Statement
15/08/22	BioElectronics : BIEL OTC Financials 30June22
22/07/22	BioElectronics’ Chairman Discusses Recent Clinical Research Findings
07/04/22	BioElectronics Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
06/04/22	BioElectronics Corporation Enters into a Distribution Agreement for RecoveryRx in Spain with Prim Group
06/04/22	BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group
30/03/22	BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico